AI Can Predict Biology. It Still Has to Survive the Human Body
Ten pharma and biotech forecasts reveal why the next AI advantage will belong to companies that can turn cheap prediction into clinical evidence, manufacturing, and patient outcomes.
Fresh research, big ideas and conversations from iPulse AI.
The latest market findings, original research, learning and updates from iPulse AI.
Clear filtersTen pharma and biotech forecasts reveal why the next AI advantage will belong to companies that can turn cheap prediction into clinical evidence, manufacturing, and patient outcomes.
Making an investment decision is easy. Making one without emotion, selective evidence, or false certainty is not. Our latest market-wide analysis shows why disagreement may be one of the most useful signals.
What SpaceX, PetroChina, and NuScale reveal about using model disagreement as a research tool instead of treating consensus as truth.
A 12-voice analysis framework ranked 400+ long-horizon opportunities. The best pick showed why upside alone is a dangerous way to read any forecast.
Showing 1–4 of 4